Combined dysfunctions of immune cells predict nosocomial infection in critically ill patients

British Journal of Anaesthesia

Volumn 111, Issue 5, 2013, Pages 778-787

  Conway Morris, A ^a,e   Anderson, N ^b   Brittan, M ^a   Wilkinson, T S ^a,c   Mcauley, D F ^d   Antonelli, J ^e   Mcculloch, C ^e   Barr, L C ^a   Dhaliwal, K ^a   Jones, R O ^a   Haslett, C ^a   Hay, A W ^e   Swann, D G ^e   Laurenson, I F ^e   Davidson, D J ^a   Rossi, A G ^a   Walsh, T S ^a,e   Simpson, A J ^a,f  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c SWANSEA UNIVERSITY   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

cross infection; intensive care; lymphocytes; neutrophils

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; HLA DR ANTIGEN;

ACINETOBACTER INFECTION; ARTICLE; BURKHOLDERIA CEPACIA INFECTION; CANDIDIASIS; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CROSS INFECTION; ENTEROBACTER CLOACAE INFECTION; ENTEROCOCCUS FAECALIS INFECTION; ESCHERICHIA COLI INFECTION; HAEMOPHILUS INFECTION; HERPES SIMPLEX; HOSPITAL INFECTION; HUMAN; IMMUNE STATUS; IMMUNOCOMPETENT CELL; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE INFECTION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MONOCYTE; NEUTROPHIL; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS INFECTION; REGULATORY T LYMPHOCYTE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TEACHING HOSPITAL;

EID: 84885901498     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet205     Document Type: Article

References (45)

1. Adibconquy M, Cavaillon J. Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Lett 2007; 581: 3723-33
2. Rittirsch D, Flierl M, Ward P. Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008; 8: 776-87
3. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-91
4. Wang T, Deng J. Molecular and cellular aspects of sepsis-induced immunosuppression. J Mol Med 2008; 86: 495-506
5. AhmedNA, McGill S, Yee J,Hu F, Michel RP, ChristouNV. Mechanisms for the diminished neutrophil exudation to secondary inflammatory sites in infected patients with a systemic inflammatory response. Crit Care Med 1999; 27: 2459-68
6. Conway Morris A, Kefala K, Wilkinson TS, et al. C5a mediates peripheral blood neutrophil dysfunction in critically ill patients.AmJRespir Crit Care Med 2009; 180: 19-28
7. Huber-Lang M, Younkin EM, Sarma JV, et al. Complement-induced impairment of innate immunity during sepsis. J Immunol 2002; 169: 3223-31
8. Conway Morris A, Brittan M, Wilkinson TS, et al. C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patients. Blood 2011; 117: 5178-88
9. Meisel C, Schefold JC, Pschowski R, et al. GM-CSF to reverse sepsis-Associatedimmunosuppression:adouble-blind randomized placebo-controlled multicenter trial.AmJRespir CritCareMed2009; 180: 640-8
10. Hotchkiss RS, Tinsley KW, Swanson PE, et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 2001; 166: 6952-63
11. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-50
12. Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011; 21: 2594-605
13. Venet F, ChungCS,MonneretG, et al.Regulatory Tcell populations in sepsis and trauma. J Leukoc Biol 2008; 83: 523-35
14. Venet F, Chung C, Kherouf H, et al. Increased circulating regulatory T cells [CD4[+]CD25[+]CD127[2]] contribute tolymphocyte anergy in septic shock patients. Intensive Care Med 2009; 35: 678-86
15. Vincent JL. Nosocomial infections in adult intensive-care units. Lancet 2003; 361: 2068-77
16. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Ann Intern Med 1991; 115: 7-12
17. Chastre J, Fagon JY. Ventilator-Associated pneumonia. Am J Respir Crit Care Med 2002; 165: 867-903
18. Baker AM, Meredith JW, Haponik EF. Pneumonia in intubated trauma patients. Microbiology and outcomes. Am J Respir Crit Care Med 1996; 153: 343-9
19. Vallés J, Pobo A, García-Esquirol O, Mariscal D, Real J, Fernández R. Excess ICU mortality attributable to ventilator-Associated pneumonia: The role of early vs late onset. Intensive Care Med 2007; 33: 1363-8
20. Hospitals in Europe Link for Infection Control through Surveillance Protocol. Available from http://helics.univ-lyon1.fr/helicshome. htm (accessed 2 February 2013
21. Davis BH. Improved diagnostic approaches to infection/sepsis detection. Exp Rev Mol Diag 2005; 5: 193-207
22. YoudenWJ. Index for rating diagnostic tests. Cancer 1950; 3: 32-5
23. Urdal DL, March CJ, Gillis S, Larsen A, Dower SK. Purification and chemical characterization of the receptor for interleukin-2 from activated human T lymphocytes and from a human T cell lymphoma cell line. Proc Natl Acad Sci USA 1984; 81: 6481-5
24. Langier S, Sade K, Kivity S. Regulatory T cells: The suppressor arm of the immune system. Autoimmunity Rev 2010; 10: 112-5
25. Solomkin JS, Jenkins MK, Nelson RD, et al. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation. Surgery 1981; 90: 319-27
26. Garibaldi RA, Burke JP, Dickman ML, Smith CB. Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med 1974; 291: 215-9
27. Hein F, Massin F, Cravoisy-Popovic A, et al. The relationship between CD4+CD25+CD127- regulatory Tcells and inflammatory response and outcome during shock states. Crit Care 2010; 14: R19
28. Heuer JG, Zhang T, Zhao J, Ding C, Cramer M, et al. Adoptive transfer of in vitro-stimulated CD4+CD25+ regulatory Tcells increases bacterial clearance and improves survival in polymicrobial sepsis. J Immunol 2005; 174: 7141-6
29. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4+ Tcells expressing the FoxP3 transcription factor. Immunity 2009 30: 899-911
30. Landelle C, Lepape A, Voirin N, et al. Low monocyte human leukocyte antigen-DRis independentlyassociated withnosocomial infections after septic shock. Intensive CareMed2010;36: 1859-66
31. Asadullah K,Woiciechowsky C, DöckeW, et al. Immunodepression following neurosurgical procedures. Crit Care Med 1995; 23: 1976-83
32. Lukaszewicz AC, Grienay M, Resche-Rigon M, et al. Monocytic HLA-DR expression in intensive care patients: Interest for prognosis and secondary infection prediction. Crit Care Med 2009; 37: 2746-52
33. Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol 2004; 4: 133-42
34. Amara U, Kalbitz M, Perl M, et al. Early expression changes of complement regulatory proteins and C5A receptor [CD88] on leukocytes after multiple injury in humans. Shock 2010; 33: 568-75
35. Unnewehr H, Rittirsch D, Sarma JV, et al. Changes and regulation of the C5a receptor on neutrophils during septic shock in humans. J Immunol 2013; 190: 4215-25
36. Pillay J, Kamp VM, van Hoffen E, et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 2012; 122: 327-36
37. Lewkowicz P, Lewkowicz N, Sasiak A, Tchórzewski H. Lipopolysaccharide-Activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J Immunol 2006; 177: 7155-63
38. Pratikaki M, Platsouka E, Sotiropoulou C, et al. Risk factors forand influence of bloodstream infections on mortality: A 1-year prospective study in a Greek intensive-care unit. Epidemiol Infect 2008; 137: 727-35
39. Vincent JL, Bihari DJ, Suter PM, Bruining HA, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care [EPIC] Study. EPIC International Advisory Committee. JAMA 1995; 274: 639-44
40. CroweM, Ispahani P, Humphreys H, Kelley T, Winter R. Bacteraemia in the adult intensive care unit of a teaching hospital in Nottingham, UK, 1985-1996. Eur J Clin Microbiol Infect Dis 1998; 17: 377-84
41. Sugerman HJ,Wolfe L, Pasquale MD, et al. Multicenter, randomized, prospective trial of early tracheostomy. J Trauma 1997; 43: 741-7
42. Moro ML, Viganó E, Cozzi Lepri A. Risk factors for central venous catheter-related infections in surgical and intensive care units. The Central Venous Catheter-Related Infections Study Group. Infect Control Hosp Epidemiol 1994; 15: 253-64
43. Levine J, KofkeA,CenL, et al.Redbloodcell transfusion is associated with infection and extracerebral complications after subarachnoid hemorrhage. Neurosurgery 2010; 66: 312-8
44. Beyersmann J, Gastmeier P, Grundmann H, et al. Transmissionassociated nosocomial infections: Prolongation of intensive care unit stay and risk factor analysis using multistate models. Am J Infect Control 2008; 36: 98-103
45. Brunson ME, Ing R, Tchervenkov JI, AlexanderJW.Variable infection risk following allogeneic blood transfusions. J Surg Res 1990; 48: 308-12